AVDL
Avadel Pharmaceuticals-adr
$11.08
Earnings Summary
Net Profits | $-64.43Mn |
Highlights
Net Profits:
Avadel Pharmaceuticals-adr’s net profit fell -1.56% since last year same period to $-64.43Mn in the Q2 2023. On a quarterly growth basis, Avadel Pharmaceuticals-adr has generated -109.3% fall in its net profits since last 3-months.
Earnings per share (EPS) Estimates
Earnings per share (EPS) estimates of the Avadel Pharmaceuticals-adr post its latest quarter earnings
EPS Estimate Current Quarter | -0.35 |
EPS Estimate Current Year | -0.35 |
Highlights
EPS Estimate Current Quarter:
Avadel Pharmaceuticals-adr’s earning per share (EPS) estimates for the current quarter stand at -0.35 - a -15.7% fall from last quarter’s estimates.
EPS Estimate Current Year:
Avadel Pharmaceuticals-adr’s earning per share (EPS) estimates for the current year stand at -0.35.
Key Ratios
Key ratios of the Avadel Pharmaceuticals-adr post its Q3 2023 earnings
Earning Per Share (EPS) | 0 |
Highlights
Earning Per Share (EPS):
Avadel Pharmaceuticals-adr’s earning per share (EPS) jumped 100% since last year same period to 0 in the Q3 2023. This indicates that the Avadel Pharmaceuticals-adr has generated 100% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2023-05-04 | -0.27 | 0 | 100% |
2023-08-09 | -0.3 | 0 | 100% |
2023-11-06 | -0.35 | 0 | 100% |
₹0 US Stocks a/c Opening Fee